LAUREN SORIANO: Open Payments
NPI 1679318703 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $285 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $97 |
| Amgen Inc. | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| ABIOMED | 2 | $60 |
| SCPHARMACEUTICALS INC. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: REPATHA, VYNDAQEL, JARDIANCE, FUROSCIX, Kerendia, AMVUTTRA, WAINUA, ELIQUIS.
Industry payments across MA — which companies pay providers there.
